Castration-resistant prostate cancer

You have access
Efficacy and Safety of Enzalutamide in a Real-World Cohort of Japanese Patients With Castration-resistant Prostate Cancer
AKIYO HORI, HARUKA SAHASHI, SORA SANO, EMIRI MATSUMIYA, MAHO ARIGA, AKARI ASANO, MIDORI SODA, CHITOSHI GOTO, TAKASHI MIZUI, HISAO KOMEDA and KIYOYUKI KITAICHI

Anticancer Research December 2020, 40 (12) 7101-7108; DOI: https://doi.org/10.21873/anticanres.14739
You have access
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA and KAZUHIRO SUZUKI

Anticancer Research September 2020, 40 (9) 5091-5095; DOI: https://doi.org/10.21873/anticanres.14512
You have access
Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer
AYA ISHII, KATSUMI SHIGEMURA, KOICHI KITAGAWA, SHIAN-YING SUNG, KUAN-CHOU CHEN, CHIANG YI-TE, MING-CHE LIU and MASATO FUJISAWA

Anticancer Research September 2020, 40 (9) 5107-5114; DOI: https://doi.org/10.21873/anticanres.14514
You have access
Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer
HIDEAKI MIYAKE, KYOHEI WATANABE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research February 2020, 40 (2) 1101-1106; DOI: https://doi.org/10.21873/anticanres.14049
You have access
Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in Japan
SHOTARO YASUOKA, TAKESHI YUASA, MASAHIRO OGAWA, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, YUKIHIRO KONDO and JUNJI YONESE

Anticancer Research October 2019, 39 (10) 5803-5809; DOI: https://doi.org/10.21873/anticanres.13784
You have access
Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional Study
MASAKI SHIOTA, MOTONOBU NAKAMURA, AKIRA YOKOMIZO, TOSHIHISA TOMODA, NAOTAKA SAKAMOTO, NARIHITO SEKI, SHUJI HASEGAWA, TAKAKAZU YUNOKI, MASAHIKO HARANO, KENTARO KUROIWA and MASATOSHI ETO

Anticancer Research August 2019, 39 (8) 4411-4414; DOI: https://doi.org/10.21873/anticanres.13612
You have access
Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy
SUGURU KADOMOTO, HIROSHI YAEGASHI, KAZUFUMI NAKASHIMA, MASASHI IIJIMA, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO, KENICHI NAKAJIMA and ATSUSHI MIZOKAMI

Anticancer Research May 2019, 39 (5) 2553-2559; DOI: https://doi.org/10.21873/anticanres.13377
You have access
Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital
KAZUFUMI NAKASHIMA, TOMOYUKI MAKINO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, MASASHI IIJIMA, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO, SHINRO MATSUO and ATSUSHI MIZOKAMI

Anticancer Research May 2019, 39 (5) 2607-2614; DOI: https://doi.org/10.21873/anticanres.13384
You have access
Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer
KOTARO SUZUKI, MARIKO SAKAMOTO, TOMOAKI TERAKAWA, JUNYA FURUKAWA, KENICHI HARADA, NOBUYUKI HINATA, YUZO NAKANO and MASATO FUJISAWA

Anticancer Research October 2018, 38 (10) 5929-5935; DOI: https://doi.org/10.21873/anticanres.12938
You have access
Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel
HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, TAKAHISA SUZUKI, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research July 2018, 38 (7) 4179-4185; DOI: https://doi.org/10.21873/anticanres.12711

Main menu

User menu

Search

Castration-resistant prostate cancer

Pages